Ignite Creation Date:
2024-05-06 @ 2:30 PM
Last Modification Date:
2024-10-26 @ 1:32 PM
Study NCT ID:
NCT04337931
Status:
TERMINATED
Last Update Posted:
2024-02-13
First Post:
2020-03-30
Brief Title:
A Study to Evaluate Sotigalimab APX005M in Subjects With Unresectable or Metastatic Melanoma
Sponsor:
Apexigen America Inc
Organization:
Apexigen America Inc
Organization Data
Organization:
Apexigen America Inc
Class:
INDUSTRY
Study ID:
APX005M-010
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Apexigen America Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None